Evaluation of the efficacy of Tamsulosine (alpha blockers) compared to phloroglucinol in improving JJ ureteral stent tolerance. A randomized controlled trial.
- Conditions
- Confirmed or potential ureteral obstruction with a uretral stenting indication.MedDRA version: 12.0Level: LLTClassification code 10050307Term: Ureteral stent insertion
- Registration Number
- EUCTR2009-012986-67-FR
- Lead Sponsor
- CHU DE POITIERS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Patients aged 18 or more.
2.Non-oncological indication to ureteral stenting
3.Informed written consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1.Any contra-indication to Tamsulosin or phloroglucinol (renal or hepatic insufficiency, allergy)
2.Pregnancy
3.Patients already treated with alpha blockers
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method